Pune, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The global Deep Brain Stimulation Devices Market size is expected to reach USD 1,676.8 million by 2026, exhibiting a CAGR of 11.6% during the forecast period. The growing awareness among the population concerning various neurological ailments will be a crucial factor in accelerating the deep brain stimulation (DBS) devices market revenue during the forecast period. In addition, the increasing cases of epilepsy around the world will fuel demand for deep brain stimulation devices in the forthcoming years. According to the World Health Organization, Epilepsy is a chronic non-communicable disease of the brain that affects people of all ages. Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. In addition, the increasing prevalence of neurological diseases in low and middle-income countries will propel the growth of the market in the foreseeable future. For instance, as per the World Health Organization survey, nearly 80% of people with epilepsy live in low- and middle-income countries.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/deep-brain-stimulation-dbs-devices-market-100559
According to the report, published by Fortune Business Insights in a report, titled “Deep Brain Stimulation (DBS) Devices Market Size, Share & Industry Analysis, By Product Type (Dual Channel Deep Brain stimulators, Single Channel Deep Brain Stimulators), By Application (Parkinson's Disease, Dystonia, Essential Tremor, Others), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast, 2019-2026” states that the value of the market stood at USD 696.4 million in 2018. The report further shares the following information:
- Comprehensive analysis of the upcoming trends and prospects in the market;
- 360-degree evaluation of the factors driving and restraining market growth;
- Detailed research into the regional and competitive landscape influencing the market;
- Careful study of the market segments.
Unveiling of Vercise Gevia™ Deep Brain Stimulation Systems to Benefit in Revenue Generation
Boston Scientific Corporation, a manufacturer of medical devices used in interventional medical specialties, including interventional radiology and interventional cardiology launched the Vercise™ Primary Cell (PC) and Vercise Gevia™ Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia Directional Lead. The new ground breaking systems feature technology designed to allow physicians to control the range, shape, position and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy and are approved by the U.S. Food and Drug Administration (FDA). The launch of the new systems by Boston Scientific Corporation will boost the Deep Brain Stimulation Devices Market trends during the forecast period owing to the engineered systems, which allows customized stimulations compared to other devices. Furthermore, Maulik Nanavaty, senior vice president and president, Neuromodulation, Boston Scientific said in a statement “Our newest generation Vercise Directional DBS Systems are supported by years of clinical data and real-world experience on the advantages of directionality and offer programming software with features that give physicians the ability to tailor therapy for individual patient needs.”
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/deep-brain-stimulation-dbs-devices-market-100559
Rising Patient Pool to Encourage Growth in Asia Pacific
Asia Pacific is expected to witness the highest growth in the market owing to the growing demand in countries such as Japan, China and India. The increasing disposable income leading to higher healthcare expenditure will also aid growth in the region. Furthermore, the growing awareness regarding various neurological conditions such as epilepsy, essential tremors and Parkinson’s disorder will fuel demand for DBS in Asia Pacific. The increasing number of medical settings such as specialty clinics and multispecialty hospitals is also a major factor stimulating growth in the region. The market in North America stood at USD 323.4 million in 2018 and is expected to flourish rapidly. The presence of major players in the region will uplift the Deep Brain Stimulation Devices Market share.
Some of the Major Companies in the Deep Brain Stimulation (DBS) Devices Market
- Abbott (ST. JUDE MEDICAL)
- Medtronic
- Boston Scientific Corporation
- Beijing PINS Medical Co., Ltd.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/deep-brain-stimulation-dbs-devices-market-100559
Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Industry Background of Deep Brain Stimulation Devices Market
4.2. New Product Launch
4.3. Porter’s five forces analysis
4.4. Key Merger and Acquisition Strategies by Top Players
4.5. Overview on Technological Advancements Pertaining to the Deep Brain Stimulators
5. Global Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product Type
5.2.1. Dual Channel Deep Brain stimulators
5.2.2. Single Channel Deep Brain Stimulators
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Parkinson's Disease
5.3.2. Dystonia
5.3.3. Essential Tremor
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Hospitals
5.4.2. Specialty Clinics
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Country
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/deep-brain-stimulation-dbs-devices-market-100559
Have a Look at Related Reports:
Spinal Cord Stimulation Market Size, Share and Industry Analysis By Product (Implantable Pulse Generator, Radiofrequency System), By Disease Indication (Failed Back Syndrome, Degenerative Disk Disease, Complex Regional Pain Syndrome, Arachnoiditis), By End Users (Hospital, Ambulatory Surgical Centers, Specialty Clinics), and Regional Forecast 2019-2026
Spinal Fusion Devices Market Size, Share & Industry Analysis, By Product Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics and Others) and Regional Forecast, 2019-2026
Pain Management Devices Market Size, Share and Industry Analysis By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Regional Forecast, 2019 - 2026
Neurodegenerative Diseases Drugs Market Size, Share and Global Trend By Drug Class (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists), By Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA)), By Route of Administration(Oral, Injection, Transdermal) By End User(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026
Neurovascular Devices/Interventional Neurology Market Size, Share & Industry Analysis, By Device Type (Stenting Systems, Embolization Devices, Neurothrombectomy Devices, and Support Devices), By Application (Cerebral Aneurysms, Ischemic Stroke and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast 2019-2026
Parkinson’s disease drugs Market Size, Share and Global Trend By Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors), Route of Administration (Oral, Injection, Transdermal), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Geography Forecast till 2026
Spinal Devices Market Size, Share & Industry Analysis, By Product Type (Fusion Devices (Cervical Devices, Thoracolumbar Devices, and Biologics), Non-Fusion Devices (Vertebral Compression Fracture Devices, Dynamic Stabilization Devices), and Stimulation Devices) By Disease Indication (Degenerative Disc Disease, Traumas & Fractures), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics and Others) and Regional Forecast, 2019-2026
Orthopedic Implants Market Size, Share & Industry Analysis, By Product (Joint Reconstruction, Spinal Implants, Trauma Implants, Dental Implants, Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/deep-brain-stimulation-dbs-devices-market-9578